The latest price target for BrightSpring Health (NASDAQ:BTSG) was reported by Wells Fargo on July 13, 2026. The analyst firm set a price target for $78.00 expecting BTSG to rise to within 12 months (a possible 12.35% upside). 41 analyst firms have reported ratings in the last year.

The latest analyst rating for BrightSpring Health (NASDAQ:BTSG) was provided by Wells Fargo, and BrightSpring Health maintained their overweight rating.

The last upgrade for BrightSpring Health Services Inc happened on December 12, 2025 when Keybanc raised their price target to $45. Keybanc previously had a sector weight for BrightSpring Health Services Inc.

There is no last downgrade for BrightSpring Health.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BrightSpring Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BrightSpring Health was filed on July 13, 2026 so you should expect the next rating to be made available sometime around July 13, 2027.

While ratings are subjective and will change, the latest BrightSpring Health (BTSG) rating was a maintained with a price target of $61.00 to $78.00. The current price BrightSpring Health (BTSG) is trading at is $69.43, which is within the analyst’s predicted range.